High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

Skin biopsy specimens of three lesions on her back were consistent with cutaneous T-cell lymphoma (CTCL). On physical examination, she had erythematous patches and plaques with ill-defined borders ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

FOXP3 + regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 21 , 2512–2518 (2007). Article CAS PubMed Google Scholar ...

It is being tested in clinical trials for cutaneous T-cell lymphoma (CTCL ... with key secondary endpoints including ...

is making significant strides in its efforts to bring innovative therapies to patients with early-stage cutaneous T-cell lymphoma (“CTCL”). The company's lead candidate, HyBryte(TM ...

Blood flow cytometry confirmed an abnormal T-cell population. These findings were suggestive of T-cell lymphoma. Serologies for tuberculosis, hepatitis, HIV, human T-lymphotropic virus type 1 or 2, ...